Observations placeholder
Ultravist
Identifier
020246
Type of Spiritual Experience
Background
A description of the experience
Iopromide is a molecule used as a contrast medium. It is marketed under the name Ultravist. It is a low osmolar, non-ionic contrast agent for intravascular use.It is commonly used in radiographic studies such as intravenous urograms, brain computer tomography (CT) and CT pulmonary angiograms (CTPAs).
On Jan, 28, 2016: 6,523 people reported to have side effects when taking Ultravist. Among them, 4 people (0.05%) have Hallucination.
Time on Ultravist when people have Hallucination :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Hallucination | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
On Feb, 7, 2016: 1,416 people reported to have side effects when taking Ultravist 150. Among them, 2 people (0.07%) has Hallucination.
On Feb, 13, 2016: 2,787 people reported to have side effects when taking Ultravist 300. Among them, 2 people (0.07%) have Hallucination.
On Feb, 13, 2016: 6,523 people reported to have side effects when taking Ultravist. Among them, 52 people (0.80%) have Death.
Time on Ultravist when people have Death :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Death | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
On Feb, 13, 2016: 1,416 people reported to have side effects when taking Ultravist 150. Among them, 13 people (0.92%) have Death.
On Jan, 28, 2016: 2,787 people reported to have side effects when taking Ultravist 300. Among them, 14 people (0.50%) have Death.
On Feb, 13, 2016: 1,299 people reported to have side effects when taking Ultravist 370. Among them, 20 people (1.54%) have Death.